Spero Therapeutics (SPRO) Cash & Equivalents Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | 14.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.81% |
| Dec 31, 2025 | -23.87% |
| Sep 30, 2025 | -36.27% |
| Jun 30, 2025 | -50.90% |
| Mar 31, 2025 | -40.58% |
| Dec 31, 2024 | -30.71% |
| Sep 30, 2024 | -18.69% |
| Jun 30, 2024 | -18.23% |
| Mar 31, 2024 | -14.53% |
| Dec 31, 2023 | -30.04% |
| Sep 30, 2023 | 85.99% |
| Jun 30, 2023 | 71.12% |
| Mar 31, 2023 | 33.48% |
| Dec 31, 2022 | -3.09% |
| Sep 30, 2022 | -55.30% |
| Jun 30, 2022 | -36.56% |
| Mar 31, 2022 | -6.40% |
| Dec 31, 2021 | 32.13% |
| Sep 30, 2021 | -9.89% |
| Jun 30, 2021 | 9.52% |
| Mar 31, 2021 | 19.70% |
| Dec 31, 2020 | 186.61% |
| Sep 30, 2020 | 174.67% |
| Jun 30, 2020 | -8.14% |
| Mar 31, 2020 | 30.30% |
| Dec 31, 2019 | -12.76% |
| Sep 30, 2019 | 12.64% |
| Jun 30, 2019 | 46.02% |
| Mar 31, 2019 | -6.01% |
| Dec 31, 2018 | -60.96% |
| Sep 30, 2018 | 59.54% |
| Dec 31, 2017 | 746.22% |
| Sep 30, 2017 | 124.94% |